Variant report
Variant | nsv877805 |
---|---|
Chromosome Location | chr3:163075070-163200865 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:290)
- CpG islands (count:0)
- Chromatin interactive region (count:17)
- LncRNA region (count:3)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
(count:17 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:163153075..163155845-chr3:163158514..163160684,2 | K562 | blood: | |
2 | chr3:163105916..163108059-chr3:163125965..163128652,2 | K562 | blood: | |
3 | chr3:163193734..163194832-chr3:163207697..163208413,4 | MCF-7 | breast: | |
4 | chr3:163093927..163096694-chr3:163097446..163100303,3 | K562 | blood: | |
5 | chr3:163105916..163108059-chr3:163125965..163128652,2 | K562 | blood: | |
6 | chr3:163153075..163155845-chr3:163158514..163160684,2 | K562 | blood: | |
7 | chr3:163098893..163101155-chr3:163335067..163337245,2 | K562 | blood: | |
8 | chr3:163099881..163101461-chr3:163102597..163105467,2 | K562 | blood: | |
9 | chr3:163090274..163091850-chr3:163098856..163100455,2 | K562 | blood: | |
10 | chr3:163099881..163101461-chr3:163102597..163105467,2 | K562 | blood: | |
11 | chr3:163193915..163194594-chr3:163339922..163340818,3 | MCF-7 | breast: | |
12 | chr3:163121369..163123913-chr3:163134434..163136619,2 | K562 | blood: | |
13 | chr16:17545591..17546532-chr3:163096602..163097414,2 | MCF-7 | breast: | |
14 | chr3:163121369..163123913-chr3:163134434..163136619,2 | K562 | blood: | |
15 | chr3:163090274..163091850-chr3:163098856..163100455,2 | K562 | blood: | |
16 | chr3:163093927..163096694-chr3:163097446..163100303,3 | K562 | blood: | |
17 | chr3:163193836..163194683-chr3:163339947..163340824,6 | MCF-7 | breast: |
(count:3 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-OTOL1-3 | chr3:163192855-163192939 | XLOC_002898 |
2 | lnc-OTOL1-3 | chr3:163196490-163197153 | XLOC_002898 |
3 | lnc-SI-4 | chr3:163079232-163079351 | ENSG00000241369 |
No data |
No data |
Variant related genes | Relation type |
---|---|
CT64 | TF binding region |
ENSG00000240792 | TF binding region |
MEOX2 | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs555212327 | chr3:163079023-163079024 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs12106974 | chr3:163079045-163079046 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs573340644 | chr3:163079049-163079050 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
4 | rs552880612 | chr3:163079062-163079063 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs573036624 | chr3:163079063-163079064 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs541921832 | chr3:163079089-163079090 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs113153835 | chr3:163079134-163079135 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540593804 | chr3:163079140-163079141 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
9 | rs561803133 | chr3:163079145-163079146 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs192630307 | chr3:163079146-163079147 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs565539182 | chr3:163079160-163079161 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs184833797 | chr3:163079222-163079223 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs111622663 | chr3:163079251-163079252 | Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs147276151 | chr3:163079289-163079290 | Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs114956243 | chr3:163079309-163079310 | Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs13075728 | chr3:163079336-163079337 | Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs369936659 | chr3:163079337-163079338 | Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs13075729 | chr3:163079338-163079339 | Active TSS | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs13075871 | chr3:163079359-163079360 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs59958993 | chr3:163079361-163079362 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs62293464 | chr3:163079363-163079364 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs533420072 | chr3:163079383-163079384 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs188382605 | chr3:163079395-163079396 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs560517130 | chr3:163079416-163079417 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs544227235 | chr3:163079424-163079425 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs549181287 | chr3:163079481-163079482 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs568980195 | chr3:163079498-163079499 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs537951163 | chr3:163079517-163079518 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs372953957 | chr3:163079518-163079519 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs4021212 | chr3:163079532-163079533 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs371599537 | chr3:163079536-163079537 | Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs571654410 | chr3:163079616-163079617 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs112770428 | chr3:163079732-163079733 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs553257733 | chr3:163079738-163079739 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs572938485 | chr3:163079747-163079748 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs143716150 | chr3:163079765-163079766 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs144979107 | chr3:163079778-163079779 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs115411260 | chr3:163079792-163079793 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs575365630 | chr3:163079823-163079824 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs544335381 | chr3:163079834-163079835 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs7636016 | chr3:163079857-163079858 | Inactive region | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs180748299 | chr3:163079866-163079867 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs540549529 | chr3:163079898-163079899 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs148138126 | chr3:163079915-163079916 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs529564982 | chr3:163079920-163079921 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs542764339 | chr3:163080013-163080014 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs141971530 | chr3:163080069-163080070 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs566550287 | chr3:163080187-163080188 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs184887438 | chr3:163080213-163080214 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs189768736 | chr3:163080254-163080255 | Inactive region | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
Bladder cancer | 21909424 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:163079000-163079600 | Active TSS | Hela-S3 | cervix |
2 | chr3:163085200-163085800 | Enhancers | Aorta | Aorta |
3 | chr3:163086600-163086800 | Enhancers | Adipose Nuclei | Adipose |
4 | chr3:163086800-163087400 | Flanking Active TSS | Adipose Nuclei | Adipose |
5 | chr3:163101600-163102800 | Enhancers | Dnd41 | blood |
6 | chr3:163103400-163104200 | Active TSS | K562 | blood |
7 | chr3:163108600-163109000 | Enhancers | Adipose Nuclei | Adipose |
8 | chr3:163108800-163110400 | Enhancers | Dnd41 | blood |
9 | chr3:163136000-163144200 | Weak transcription | Aorta | Aorta |
10 | chr3:163144200-163144400 | ZNF genes & repeats | Aorta | Aorta |
11 | chr3:163156800-163157400 | Enhancers | Adipose Nuclei | Adipose |
12 | chr3:163166400-163168600 | Weak transcription | Aorta | Aorta |
13 | chr3:163168600-163169400 | ZNF genes & repeats | Aorta | Aorta |
14 | chr3:163169400-163179400 | Weak transcription | Aorta | Aorta |
15 | chr3:163171800-163172000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
16 | chr3:163172800-163173200 | Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
17 | chr3:163172800-163173400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
18 | chr3:163176600-163177000 | Enhancers | Hela-S3 | cervix |
19 | chr3:163177000-163177400 | Active TSS | Hela-S3 | cervix |
20 | chr3:163179200-163180000 | Enhancers | Adipose Nuclei | Adipose |
21 | chr3:163179400-163180000 | Enhancers | Aorta | Aorta |